Librela Solution for Injection for Dogs 5mg (5kg-10kg) 2支盒 橙 **需冷藏**

$2900.0

允許無庫存下單

分類: ,

描述

Librela 用於緩解狗與骨關節炎相關的疼痛。Librela 是一種單株抗體療法,以神經生長因子 (NGF) 為目標,以控制犬類骨關節炎。服用 Librela 的狗狗活動能力增強,疼痛減輕。Librela 的功能類似於天然產生的抗體,並透過正常的蛋白質降解途徑消除,肝臟或腎臟的參與最少。該產品每月注射一次。
請記得將本產品直立存放在原包裝中,並冷藏在 2 至 8°c 之間。
原料
貝丁韋特單抗
劑量和給藥
用於皮下注射。
劑量和治療方案
建議劑量為0.5-1.0mg/kg體重,每月一次。
對於體重 <5.0 公斤的狗:
從單一 5 mg/ml 小瓶中無菌抽取 0.1 ml/kg 並皮下給藥。
對於 5 至 60 公斤之間的狗,請根據下表服用小瓶中的全部內容物(1 毫升):
待施用的LIBRELA強度(毫克)
犬體重(公斤)
5
10
15
20
30
5.0 – 10.0
1 瓶
10.1 – 20.0
1 瓶
20.1 – 30.0
1 瓶
30.1 – 40.0
1 瓶
40.1 – 60.0
1 瓶
60.1 – 80.0
2 瓶
80.1 – 100.0
1 瓶
1 瓶
100.1 – 120.0
2 瓶
對於體重超過 60 公斤的狗,單次給藥需要超過一瓶的內容物。在這些情況下,將每個所需小瓶中的內容物抽入同一注射器中,並以單次皮下注射(2 ml)給藥。
Librela is used for the alleviation of pain associated with osteoarthritis in dogs.
Librela is a monoclonal antibody therapy administered to target the nerve growth factor (NGF) to control canine osteoarthritis.Dogs taking Librela experience increased mobility and decreased pain.Librela functions like naturally produced antibodies and is eliminated via normal protein degradation pathways with minimal involvement of the liver or kidneys.The product is administered by monthly injection.

SIZES

Librela Solution for Injection for Dogs 5mg (5kg – 10kg) is available in the following size:
  • 2 x 1ml Vials
Remember to store this product upright in its original packaging and refrigerate between 2 & 8°c. INGREDIENTS
Bedinvetmab
Dosage and administration
For subcutaneous use.
Dosage and treatment schedule
The recommended dose is 0.5-1.0 mg/kg bodyweight, once a month.
For dogs weighing <5.0 kg:
Aseptically withdraw 0.1 ml/kg from a single 5 mg/ml vial and administer subcutaneously.
For dogs between 5 and 60 kg administer the entire content of the vial (1 ml) according to the table below:
LIBRELA strength (mg) to be administered
Bodyweight (kg) of dog
5
10
15
20
30
5.0 – 10.0
1 vial
10.1 – 20.0
1 vial
20.1 – 30.0
1 vial
30.1 – 40.0
1 vial
40.1 – 60.0
1 vial
60.1 – 80.0
2 vials
80.1 – 100.0
1 vial
1 vial
100.1 – 120.0
2 vials
For dogs above 60 kg, the contents of more than one vial are required to administer a single dose. In those cases, withdraw the content from each required vial into the same syringe and administer as a single subcutaneous injection (2 ml).

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping